HCA Healthcare Management

Management criteria checks 2/4

HCA Healthcare's CEO is Sam Hazen, appointed in Jan 2019, has a tenure of 5.92 years. total yearly compensation is $21.32M, comprised of 7.1% salary and 92.9% bonuses, including company stock and options. directly owns 0.52% of the company’s shares, worth $423.72M. The average tenure of the management team and the board of directors is 5.9 years and 8.9 years respectively.

Key information

Sam Hazen

Chief executive officer

US$21.3m

Total compensation

CEO salary percentage7.1%
CEO tenure5.9yrs
CEO ownership0.5%
Management average tenure5.9yrs
Board average tenure8.9yrs

Recent management updates

Recent updates

Shareholders Would Enjoy A Repeat Of HCA Healthcare's (NYSE:HCA) Recent Growth In Returns

Nov 10
Shareholders Would Enjoy A Repeat Of HCA Healthcare's (NYSE:HCA) Recent Growth In Returns

HCA Healthcare Q3 Earnings Preview: Step Change In Value (Rating Upgrade)

Oct 22

HCA Healthcare, Inc. (NYSE:HCA) Not Lagging Market On Growth Or Pricing

Oct 16
HCA Healthcare, Inc. (NYSE:HCA) Not Lagging Market On Growth Or Pricing

HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 63% Above Its Share Price

Oct 01
HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 63% Above Its Share Price

HCA Healthcare: Still A Great Play On Long-Term Growth And Valuation

Sep 28

Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?

Sep 16
Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?

Does HCA Healthcare (NYSE:HCA) Have A Healthy Balance Sheet?

Sep 01
Does HCA Healthcare (NYSE:HCA) Have A Healthy Balance Sheet?

Results: HCA Healthcare, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Jul 26
Results: HCA Healthcare, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Are Investors Undervaluing HCA Healthcare, Inc. (NYSE:HCA) By 27%?

Jun 21
Are Investors Undervaluing HCA Healthcare, Inc. (NYSE:HCA) By 27%?

HCA Healthcare, Inc.'s (NYSE:HCA) P/E Still Appears To Be Reasonable

Jun 06
HCA Healthcare, Inc.'s (NYSE:HCA) P/E Still Appears To Be Reasonable

Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?

May 21
Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?

HCA Healthcare, Inc. Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next

Apr 30
HCA Healthcare, Inc. Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next

Capital Investment Trends At HCA Healthcare (NYSE:HCA) Look Strong

Apr 11
Capital Investment Trends At HCA Healthcare (NYSE:HCA) Look Strong

HCA Healthcare Is Finally At Fair Value (Rating Downgrade)

Mar 19

HCA Healthcare: Improving Margins Now Reflected In Shares (Rating Downgrade)

Feb 29

HCA Healthcare (NYSE:HCA) Is Increasing Its Dividend To $0.66

Feb 25
HCA Healthcare (NYSE:HCA) Is Increasing Its Dividend To $0.66

HCA Healthcare (NYSE:HCA) Is Paying Out A Larger Dividend Than Last Year

Feb 05
HCA Healthcare (NYSE:HCA) Is Paying Out A Larger Dividend Than Last Year

HCA Healthcare, Inc. (NYSE:HCA) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02
HCA Healthcare, Inc. (NYSE:HCA) Analysts Are Pretty Bullish On The Stock After Recent Results

HCA Healthcare, Inc. (NYSE:HCA) Shares Could Be 40% Below Their Intrinsic Value Estimate

Jan 21
HCA Healthcare, Inc. (NYSE:HCA) Shares Could Be 40% Below Their Intrinsic Value Estimate

At US$276, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?

Jan 08
At US$276, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?

HCA Healthcare, Inc.'s (NYSE:HCA) Share Price Is Matching Sentiment Around Its Earnings

Dec 25
HCA Healthcare, Inc.'s (NYSE:HCA) Share Price Is Matching Sentiment Around Its Earnings

HCA Healthcare Continues To Impress

Dec 14

Should You Be Adding HCA Healthcare (NYSE:HCA) To Your Watchlist Today?

Dec 11
Should You Be Adding HCA Healthcare (NYSE:HCA) To Your Watchlist Today?

HCA Remains Attractive Despite A JV Misstep

Nov 20

HCA Healthcare: Rx For Success

Oct 10

HCA Healthcare: Impact Of Medicare Advantage Growth And Demographic Shift

Sep 30

HCA Healthcare Is Beating The Industry

Sep 13

HCA Healthcare's Service Optimization And Capabilities Support Long-Run Growth

Jul 03

CEO Compensation Analysis

How has Sam Hazen's remuneration changed compared to HCA Healthcare's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$6b

Jun 30 2024n/an/a

US$6b

Mar 31 2024n/an/a

US$5b

Dec 31 2023US$21mUS$2m

US$5b

Sep 30 2023n/an/a

US$6b

Jun 30 2023n/an/a

US$6b

Mar 31 2023n/an/a

US$6b

Dec 31 2022US$15mUS$2m

US$6b

Sep 30 2022n/an/a

US$5b

Jun 30 2022n/an/a

US$7b

Mar 31 2022n/an/a

US$7b

Dec 31 2021US$21mUS$1m

US$7b

Sep 30 2021n/an/a

US$7b

Jun 30 2021n/an/a

US$5b

Mar 31 2021n/an/a

US$5b

Dec 31 2020US$30mUS$1m

US$4b

Sep 30 2020n/an/a

US$3b

Jun 30 2020n/an/a

US$3b

Mar 31 2020n/an/a

US$3b

Dec 31 2019US$27mUS$1m

US$4b

Sep 30 2019n/an/a

US$3b

Jun 30 2019n/an/a

US$4b

Mar 31 2019n/an/a

US$4b

Dec 31 2018US$10mUS$1m

US$4b

Sep 30 2018n/an/a

US$3b

Jun 30 2018n/an/a

US$3b

Mar 31 2018n/an/a

US$3b

Dec 31 2017US$10mUS$1m

US$2b

Compensation vs Market: Sam's total compensation ($USD21.32M) is above average for companies of similar size in the US market ($USD12.58M).

Compensation vs Earnings: Sam's compensation has increased by more than 20% in the past year.


CEO

Sam Hazen (64 yo)

5.9yrs

Tenure

US$21,315,984

Compensation

Mr. Samuel N. Hazen, also known as Sam, serves as Director at HCA Healthcare, Inc. He serves as Chief Executive Officer of HCA Healthcare Inc. since January 01, 2019 and has been its Director since Septemb...


Leadership Team

NamePositionTenureCompensationOwnership
Samuel Hazen
CEO & Director5.9yrsUS$21.32m0.52%
$ 423.7m
Jon Foster
Executive VP & COO1.9yrsUS$8.70m0.073%
$ 59.2m
Erol Akdamar
President of American Group11.9yrsUS$5.40m0.050%
$ 40.7m
Timothy McManus
President of National Group8.4yrsUS$5.58m0.011%
$ 8.6m
Thomas Frist
Founder & Chairman Emeritusno dataUS$362.11k0.19%
$ 153.1m
Michael Marks
CFO & Executive Vice Presidentless than a yearno data0.028%
$ 22.3m
Christopher Wyatt
Senior VP8.7yrsno data0.016%
$ 12.9m
Chad Wasserman
Senior VP & Chief Information Officerless than a yearno data0.00062%
$ 502.1k
Michael McAlevey
Executive VP and Chief Legal & Administrative Officer2.9yrsUS$6.47m0.0016%
$ 1.3m
Frank Morgan
Vice President of Investor Relations2.9yrsno datano data
Kathleen Whalen
Senior VP and Chief Ethics & Compliance Officer5.9yrsno data0.0037%
$ 3.0m
Deborah Reiner
Senior Vice President of Marketing & Corporate Affairs7.2yrsno data0.0014%
$ 1.1m

5.9yrs

Average Tenure

60yo

Average Age

Experienced Management: HCA's management team is seasoned and experienced (5.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Samuel Hazen
CEO & Director6.3yrsUS$21.32m0.52%
$ 423.7m
Thomas Frist
Founder & Chairman Emeritusno dataUS$362.11k0.19%
$ 153.1m
Michael Michelson
Independent Director6.9yrsUS$389.78k0%
$ 0
Robert Dennis
Independent Director10.8yrsUS$377.95k0.0016%
$ 1.3m
Nancy-Ann DeParle
Independent Director10.8yrsUS$334.78k0.0080%
$ 6.4m
Thomas Frist
Chairman of the Board18.9yrsUS$399.61kno data
Meg Crofton
Independent Director5.8yrsUS$319.78k0.0025%
$ 2.0m
Hugh Johnston
Independent Director3.3yrsUS$339.78k0.0010%
$ 842.3k
Wayne Riley
Independent Director12.9yrsUS$349.78k0.0043%
$ 3.5m
William Frist
Director15.9yrsUS$309.70k0.16%
$ 129.7m
Andrea Smith
Independent Director2.9yrsUS$324.78k0.0014%
$ 1.2m
John McWilliams
Director of HealthONEno datano datano data

8.9yrs

Average Tenure

65yo

Average Age

Experienced Board: HCA's board of directors are considered experienced (8.9 years average tenure).